In April, the company announced a financial restructuring plan that would reduce M*Modal’s debt by more than 55 percent, approximately $350 million. M*Modal has continued operations throughout the bankruptcy period.
“We are pleased to have reached this important final milestone, and look forward to emerging from the financial restructuring process which will dramatically reduce our debt, strengthen our balance sheet and provide significant financial flexibility,” said M*Modal CEO Duncan James in a news release. “With renewed financial strength, we will continue our focus on delivering innovative solutions to our healthcare customers and growing market share.”
More Articles on the Health IT Market:
Siemens Considering Selling Health IT Division
Health IT Tech Hubs Growing in Chicago, Miami
The Most Exciting New Technology: 3 CIOs Reflect
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
